By Mark Chael --
On Friday, April 27, 2007 at 9:00 am, the Seton Hall University School of Law (SHU Law) will hold a press conference to announce the establishment of the Center for Health & Pharmaceutical Law. The mission of the new Center will be "to address the evolving legal and public policy framework of modern drug and device regulation and practice."
As reported by the Associated Press, the Center will be funded primarily by endowments totaling more than $8 million from Bristol-Myers Squibb, Johnson & Johnson, Sanofi-Avenis, and Schering-Plough. Bristol-Myers Squibb itself will be donating $5 million to endow a professorship in corporate governance and business.
The research and policy center will focus on various issues affecting the pharmaceutical and medical device industries, including legal, business ethics, regulatory, enforcement, among others. According to Ms. Denise Pinney, who is the Assistant Dean of Health, Science, and Technology Law at SHU Law, the research will include not only the view of industry personnel and legal scholars, but also the views of patients, doctors, politicians, and students.
More information about the press conference can be found here.
Comments